Nidek

Japanese ophthalmic-equipment manufacturer — full-line vendor across OCT, fundus imaging, perimetry, refractive diagnostics, lasers, and lens-edging. Particularly strong in optometry and general-ophthalmology markets globally; smaller share than Zeiss / Heidelberg / Topcon in academic retinal practice but durable presence in community ophthalmology and Asian markets.

Company history

1971 — founded in Japan.
1980s–2000s — establishes broad ophthalmic-equipment portfolio across diagnostics and surgical lasers.
2010s — RS-3000 OCT line establishes Nidek's retinal-imaging presence.
2020s — continued evolution of the Mirante (multi-modal retinal imaging) and RS-330 OCT generations.

Product line

OCT

RS-3000 Advance — spectral-domain OCT.
RS-330 — current-generation OCT.
Mirante — multi-modal retinal imaging (cSLO + OCT + fundus + autofluorescence).

Fundus / retinal imaging

AFC-330 — non-mydriatic auto-tracking fundus camera.
Mirante integration.

Refractive diagnostics

AR-1 / RT-6100 — auto-refractor / auto-keratometer.
OPD-Scan III — wavefront aberrometer.

Lasers

MC-500 Vixi — multi-wavelength retinal laser.
CSO / YC — YAG / SLT lasers.

Lens edging / optical-shop

LEX-1200 / Le-9000 — lens-edging systems for optical retail.

Distinctive technology

Multi-modal Mirante — combines confocal SLO, OCT, color fundus, fundus autofluorescence, fluorescein / ICG angiography in a single device. Functional analog to Heidelberg Spectralis modular platform at different price tier.
Optometry-friendly workflow — auto-alignment / auto-focus / single-button operation across OCT, fundus, refractive diagnostics. Designed for technician operators in optical-retail and community-ophthalmology contexts.

Market position

Top-tier in optometry / community ophthalmology globally, particularly strong in Asia-Pacific. Smaller academic-retina presence than Zeiss / Heidelberg / Topcon. Direct competitors: Topcon Maestro (mainstream OCT), Optovue / Visionix, Canon ophthalmic.

Refurb posture

Established refurb supply in optometry / community-ophthalmology turnover.
Software-version status drives capability tier.
Vendor lock-in on serial patient comparison as with all OCT.